Retinal pigment epithelial expression of complement regulator CD46 is altered early in the course of geographic atrophy |
| |
| Authors: | Vogt Susan D Curcio Christine A Wang Lan Li Chuan-Ming McGwin Gerald Medeiros Nancy E Philp Nancy J Kimble James A Read Russell W |
| |
| Affiliation: | aDepartment of Ophthalmology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States;bDepartment of Surgery, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States;cDepartment of Pathology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States;dDepartment of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, United States;eRetina Specialists of North Alabama, Huntsville, AL, United States;fDepartment of Pathology, Thomas Jefferson University, Philadelphia, PA, United States;gRetina Specialists of Alabama, Birmingham, AL, United States |
| |
| Abstract: | In geographic atrophy (GA), the non-neovascular end stage of age-related macular degeneration (AMD), the macular retinal pigment epithelium (RPE) progressively degenerates. Membrane cofactor protein (MCP, CD46) is the only membrane-bound regulator of complement expressed on the human RPE basolateral surface. Based on evidence of the role of complement in AMD, we hypothesized that altered CD46 expression on the RPE would be associated with GA development and/or progression. Here we report the timeline of CD46 protein expression changes across the GA transition zone, relative to control eyes, and relative to events in other chorioretinal layers. Eleven donor eyes (mean age 87.0 ± 4.1 yr) with GA and 5 control eyes (mean age 84.0 ± 8.9 yr) without GA were evaluated. Macular cryosections were stained with PASH for basal deposits, von Kossa for calcium, and for CD46 immunoreactivity. Internal controls for protein expression were provided by an independent basolateral protein, monocarboxylate transporter 3 (MCT3) and an apical protein, ezrin. Within zones defined by 8 different semi-quantitative grades of RPE morphology, we determined the location and intensity of immunoreactivity, outer segment length, and Bruch’s membrane calcification. Differences between GA and control eyes and between milder and more severe RPE stages in GA eyes were assessed statistically. Increasing grades of RPE degeneration were associated with progressive loss of polarity and loss of intensity of staining of CD46, beginning with the stages that are considered normal aging (grades 0–1). Those GA stages with affected CD46 immunoreactivity exhibited basal laminar deposit, still-normal photoreceptors, and concomitant changes in control protein expression. Activated or anteriorly migrated RPE (grades 2–3) exhibited greatly diminished CD46. Changes in RPE CD46 expression thus occur early in GA, before there is evidence of morphological RPE change. At later stages of degeneration, CD46 alterations occur within a context of altered RPE polarity. These changes precede degeneration of the overlying retina and suggest that therapeutic interventions be targeted to the RPE. |
| |
| Keywords: | age-related macular degeneration geographic atrophy complement CD46 inflammation immunohistochemistry histopathology human |
| 本文献已被 ScienceDirect PubMed 等数据库收录！ |
|
